Kristen and Sarah celebrate receiving the 2019 Stroke Gold Plus with Target: Stroke Honor Roll Elite Plus award. Left to Right: Kristen Henry, RN, Sarah Lear, RN, Yunxia Wang, MD, Colleen Lechtenberg, MD, Janice Sandt, RN, and Stacy Smith, RN.
Measures:
Percent of acute ischemic stroke patients with diabetes who arrive at the hospital within 210 minutes (3.5 hours) of time last known well and for whom IV t-PA was initiated at this hospital within 270 minutes (4.5 hours) of time last known well.
Percent of patients with ischemic stroke or TIA and diabetes who receive antithrombotic therapy by the end of hospital day two.
Percent of patients with diabetes and an ischemic stroke, or a hemorrhagic stroke, or stroke not otherwise specified who receive VTE prophylaxis the day of or the day after hospital admission.
Percent of patients with an ischemic stroke or TIA and diabetes prescribed antithrombotic therapy at discharge.
Percent of patients with an ischemic stroke or TIA with atrial fibrillation/flutter and diabetes discharged on anticoagulation therapy.
Percent of patients with ischemic or hemorrhagic stroke or TIA and diabetes and a history of smoking cigarettes, who are, or whose caregivers are, given smoking cessation advice or counseling during hospital stay.
Percent of ischemic stroke or TIA patients with diabetes who are prescribed high-intensity statin therapy at discharge OR, if >75 years of age, are prescribed at least moderate-intensity statin therapy at discharge.
Percent of diabetic patients or newly-diagnosed diabetics receiving diabetes treatment in the form of glycemic control (diet or medication) or follow-up appointment for diabetes management scheduled at discharge.
Percent of ischemic stroke or TIA patients with diabetes who receive therapeutic lifestyle recommendations at discharge.
Measures:
Percent of acute ischemic stroke patients who arrive at the hospital within 210 minutes (3.5 hours) of time last known well and for whom IV t-PA was initiated at this hospital within 270 minutes (4.5 hours) of time last known well.
Percent of patients with ischemic stroke or TIA who receive antithrombotic therapy by the end of hospital day 2.
Percent of patients with ischemic stroke, hemorrhagic stroke, or stroke not otherwise specified who receive VTE prophylaxis the day of or the day after hospital admission.
Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge.
Percent of patients with an ischemic stroke or TIA with atrial fibrillation/flutter discharged on anticoagulation therapy.
Percent of patients with ischemic, hemorrhagic stroke, or TIA with a history of smoking cigarettes, who are, or whose caregivers are, given smoking cessation advice or counseling during hospital stay.
Percent of ischemic stroke or TIA patients who are prescribed high-intensity statin therapy at discharge OR, if >75 years of age, are prescribed at least moderate-intensity statin therapy at discharge.
Measures:
Percent of stroke patients who undergo screening for dysphagia with an evidence-based bedside testing protocol approved by the hospital before being given any food, fluids, or medication by mouth.
Percent of patients with stroke or TIA or their caregivers who were given education and/or educational materials during the hospital stay address all of the following: personal risk factors for stroke, warning signs for stroke, activation of emergency medical system, need for follow-up after discharge, and medications prescribed.
Percent of patients with stroke who were assessed for rehabilitation services.
Percent of acute ischemic stroke patients receiving IV-tPA during the hospital stay who have a time from hospital arrival to initiation of IV-tPA (door-to-needle time) of 60 minutes or less.
Percent of ischemic stroke or TIA patients with a documented lipid profile.
Percent of ischemic stroke and stroke not otherwise specified patients with a score reported for NIH Stroke Scale (initial).